Physician profile
Ryan M Baker
NPI 1821480047
$8,884.23
in general payments reported to CMS, 2019-2025
12 companies · $2,381 in 2025
The $2,381 reported for 2025 was more than what 95% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $928 · 2022: $4,805 · 2023: $403 · 2024: $367 · 2025: $2,381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,250 · Food and Beverage: $901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,250.00 |
| Food and Beverage | $901.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $5,438.57 | 2021-2022 | |
| Galderma Laboratories, L.P. | $2,418.85 | 2021-2025 | Dysport |
| Abbvie INC. | $826.96 | 2023-2025 | |
| Medtronic, INC. | $52.00 | 2021 | |
| Horizon Therapeutics Plc | $41.00 | 2021 | |
| Convatec INC. | $17.24 | 2021 | |
| Abbott Laboratories | $16.64 | 2023 | Amplatzer Talisman |
| Merck Sharp & Dohme LLC | $15.96 | 2021 | |
| Melinta Therapeutics, LLC | $15.55 | 2021 | |
| Amgen INC. | $15.41 | 2021 | |
| Antares Pharma, INC. | $13.10 | 2021 | |
| Mission Pharmacal Company | $12.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.